Atria Investments’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Atria Investments's OGN Position: Q2 2026 in Review
Atria Investments increased its Organon & Co (OGN) stake by 20% in Q2 2026, buying an estimated $68.7K and bringing the position to 34,150 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.
Atria Investments first reported a position in OGN in Q3 2025 and has held it in 4 quarters since. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Atria Investments held 34,150 shares of Organon & Co worth $462K as of Q2 2026.
- Atria Investments bought 5,744 Organon & Co shares in Q2 2026, an estimated $68.7K.
- Organon & Co made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1568 holding.
- Atria Investments first reported a position in Organon & Co in Q3 2025 and has held it in 4 quarters since.
- 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.